Valuation: DiaSorin S.p.A.

Market Cap 3.79B 4.37B 3.55B 3.24B 6.09B 417B 6.2B 41.61B 16.3B 209B 16.42B 16.07B 697B P/E 2026 *
22.2x
P/E 2027 * 19.6x
Enterprise Value 4.5B 5.19B 4.21B 3.84B 7.23B 495B 7.35B 49.37B 19.34B 248B 19.49B 19.06B 827B EV / Sales 2026 *
3.64x
EV / Sales 2027 * 3.31x
Free-Float
37.17%
Yield 2026 *
1.7%
Yield 2027 * 1.78%
1 day-3.45%
1 week-1.31%
Current month+2.89%
1 month+6.42%
3 months+8.29%
6 months-0.35%
Current year+7.75%
1 week 73.3
Extreme 73.3
76.58
1 month 63
Extreme 63
76.58
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
1/28/26 A Buy

Chief Executive Officer

7,500 0.0134%
1/8/26 A Buy

Director

700 0.0013%
1/8/26 A Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
-3.42%-1.31%-10.16%-19.00% 4.37B
+0.49%+2.50%+203.57%+367.09% 22.15B
-1.36%+1.25%-41.81%-22.50% 10.02B
-2.03%+24.34%+360.66%+17.74% 7.62B
+0.14%-0.65%+87.09%+46.06% 6.57B
-3.05%+34.07%-32.05% - 6.54B
-1.45%+3.03%-15.02%-12.39% 5.63B
-2.05%+5.20%+76.47%+98.21% 4.4B
-0.70%-2.80%-22.96%-35.16% 2.76B
+4.32%+13.78%-51.85%+177.04% 1.47B
Average -0.90%+8.66%+55.39%+68.56% 7.15B
Weighted average by Cap. -0.87%+8.31%+101.62%+135.19%

Financials

2026 *2027 *
Net sales 1.23B 1.42B 1.16B 1.05B 1.98B 136B 2.02B 13.55B 5.31B 68B 5.35B 5.23B 227B 1.31B 1.51B 1.23B 1.12B 2.11B 144B 2.14B 14.38B 5.63B 72.15B 5.67B 5.55B 241B
Net income 181M 208M 169M 154M 290M 19.87B 295M 1.98B 777M 9.95B 782M 765M 33.18B 205M 237M 192M 176M 330M 22.62B 336M 2.26B 884M 11.32B 890M 871M 37.77B
Net Debt 707M 815M 661M 604M 1.14B 77.77B 1.15B 7.76B 3.04B 38.92B 3.06B 2.99B 130B 541M 625M 507M 462M 870M 59.59B 885M 5.94B 2.33B 29.83B 2.35B 2.29B 99.51B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,260
Date Price Change Volume
12/08/26 73.96 -3.42% 249,069
11/08/26 €76.58 +0.39% 176,011
10/08/26 €76.28 +1.17% 141,673
07/08/26 €75.40 +1.26% 251,852
06/08/26 €74.46 -0.61% 118,192
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
76.58EUR
Average target price
71.66EUR
Spread / Average Target
-6.42%

Quarterly revenue - Rate of surprise